Tiziana Life Sciences Ltd
TLSA | NASDAQ
$0.80
-$0.10 (-11.57%)
At close: Oct 30, 2026, 4:00 PM ET
$0.90
+$0.10 (+12.50%)
Pre-market:
Nov 2, 2026, 4:46 AM ET
-11.57%
(1D)No price chart data available for 1D timeframe.
Rating
41.8
+4.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #492/1028 (Top 48%)
Key Statistics
Market Data
Market Cap $101.81M
1D Range
0.79 0.92
52W Range
0.77 1.92
Valuation (TTM)
PE -1.90
PB -37.06
EV/EBITDA -4.25
Valuation (NTM)
Forward PE N/A
Forward PEG -0.60
Price Target $7.00
Cash Flow
FCF Yield -13.2%
SBC Adj. FCF Yield -13.2%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 144.0% |
-1.4%
FCF 3Y | 5Y 4.5% |
-12.5%
Returns
ROA -216.0%
ROE 1869.1%
ROIC 1284.8%
Financial Health
Net Cash
$3.07M
Current Ratio 0.69
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship i...
Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Nov 20, 2018
Website www.tizianalifesciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$7.00
Upside
+775.00%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TLSA